Clindamycin Phosphate Injection — FDA Drug Shortage

Current — Baxter Healthcare

The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on Mar 21, 2023.

Shortage details

Status
Current
Company
Baxter Healthcare
Package NDC
0338-3612-50
Dosage Form
Injection
Presentation
Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)
Initial Posting
Mar 21, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.